Hepatocellular carcinoma in non-alcoholic steatohepatitis: Growing evidence of an epidemic?
about
Chemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agentsCould metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease?Simple sugar intake and hepatocellular carcinoma: epidemiological and mechanistic insightRole of epigenetic aberrations in the development and progression of human hepatocellular carcinomaNASH Cirrhosis - the New Burden in Liver Transplantation: How Should It Be Managed?Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populationsPopulation-attributable fractions of risk factors for hepatocellular carcinoma in the United States.Low-dose Cd induces hepatic gene hypermethylation, along with the persistent reduction of cell death and increase of cell proliferation in rats and mice.The relevance of liver histology to predicting clinically meaningful outcomes in nonalcoholic steatohepatitis.Questionnaire survey on lifestyle of patients with nonalcoholic steatohepatitis.[Non fibrolamellar hepatocellular carcinoma on a healthy liver].Clinical features and outcome of cryptogenic hepatocellular carcinoma compared to those of viral and alcoholic hepatocellular carcinoma.Characteristics of hepatocellular carcinoma in cirrhotic and non-cirrhotic non-alcoholic fatty liver disease.The role of the gut microbiome in the development and progression of liver cirrhosis and hepatocellular carcinoma.Effect of Lipopolysaccharide on the Progression of Non-Alcoholic Fatty Liver Disease in High Caloric Diet-Fed Mice.Normal liver enzymes are correlated with severity of metabolic syndrome in a large population based cohort.A multi-mineral natural product inhibits liver tumor formation in C57BL/6 mice.Calcium Reduces Liver Injury in Mice on a High-Fat Diet: Alterations in Microbial and Bile Acid Profiles.Antioxidant therapy in nonalcoholic steatohepatitis.Dietary fatty acids and risk of hepatocellular carcinoma in the Singapore Chinese health study.Outcomes of Hepatic Resection in Intrahepatic Cholangiocarcinoma Patients with Diabetes, Hypertension, and Dyslipidemia: Significance of Routine Follow-Up.Modified cisplatin/interferon α-2b/doxorubicin/5-fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinomaHepatocarcinogenesis in non-alcoholic fatty liver disease in Japan.Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: a review of human studies.Significant biomarkers for the management of hepatocellular carcinoma.Non-alcoholic fatty liver disease-related hepatocellular carcinoma: a sleeping tiger in the Asia Pacific.Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, and Prevention.Herbal Medicine Offered as an Initiative Therapeutic Option for the Management of Hepatocellular Carcinoma.TNF-dependent signaling pathways in liver cancer: promising targets for therapeutic strategies?.Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.Clinicopathological characteristics of non-B non-C hepatocellular carcinoma without past hepatitis B virus infection.A rapidly progressive and fatal case of nonalcoholic steatohepatitis following pancreaticoduodenectomy.The association between non-alcoholic steatohepatitis and intrahepatic cholangiocarcinoma: A hospital based case-control study.Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter survey.S-Allyl cysteine improves nonalcoholic fatty liver disease in type 2 diabetes Otsuka Long-Evans Tokushima Fatty rats via regulation of hepatic lipogenesis and glucose metabolism.Nonalcoholic fatty liver disease: Fibrosis portends a worse prognosis.Increased hepatic oxidative DNA damage in patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma.Clinical patterns of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD): a multicenter prospective study.Hepatic and extrahepatic malignancies in cirrhosis caused by nonalcoholic steatohepatitis and alcoholic liver disease.The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groups.
P2860
Q26772302-65F90C91-D203-4F37-BFA0-F67F46D1369FQ26824893-AF30E694-058D-4FFD-BF5A-53D53E566E07Q26864513-43E5E3D4-DF46-4EFD-BC5C-7B32499F4C8AQ27023524-8DDD59C9-FF51-4977-83FF-9EDF94A194C5Q28079900-F07542D7-5037-4E25-8294-B497D16135C7Q28386598-854C0B2C-81C2-48D0-996A-8F41C5EC355DQ30584496-1A78287F-26EB-47C6-8A7C-927897D133B3Q34212012-EB396FF7-CA5C-4D38-B215-22BB546E40DCQ34252404-135ECA70-8895-4282-93D2-B677785248E5Q34489935-457B2CD2-C011-4DBD-B4C3-C87557BFC8A9Q34539639-F5D75141-3D5C-4314-A291-8436EB85F80CQ34799936-FE0F7C61-F4D9-4126-AECB-D88151F172C2Q35012074-8B8058BB-3918-4D30-8039-18D3E1911DBEQ35203669-FDD0FAE1-8A25-4F16-A6AF-FD80A79DAEFFQ35829297-84831FC5-5C16-4912-BC35-831CB5A3E8C4Q35948791-862ABBD3-C9A2-4638-AC7E-37ABB4EC4325Q35990259-FF7A1C6E-ED7F-434F-8898-8DB2C473BF9FQ36194038-1ACF5A20-EE4E-42DC-BB36-3C15D107A3B6Q36440119-D261984D-CF4D-4D91-B993-9CAD12512493Q36777552-F66CE3B1-314F-4FBD-B1D0-C0E7BB4F07A0Q37000684-77F16645-2952-4FF9-B8FF-A98E64709BFAQ37179530-E2874781-C9DE-4B1D-A5AC-87CE0EA69654Q38164076-8F025D6B-F925-4EE3-BDF2-5FE3772F79D0Q38313236-94471242-9DD0-4509-A28E-4F4D65CA7DBEQ38412315-0326BDD7-9035-499D-8402-FBF496803060Q38552383-A7DE48ED-D9F7-4E84-8C95-A0E9B3B8A37EQ38584060-509AA4A5-5913-41B1-AED2-622E070CC64AQ38734645-9398E7BE-77A3-4DC5-BA15-414E8716C83DQ39529070-B3B921A1-EF5D-4EC6-AC2B-294534E6F4EBQ40332880-A29EF3CE-2705-41CE-9A9D-FCB5CFB250D8Q40706511-1FCE8EBF-6759-41C1-A9B1-998D78789C09Q40728791-325B5C11-5036-4794-B2ED-47A522C361CAQ40842861-32A05373-997A-43ED-AEBA-9352D947508CQ41235262-38D12A94-5183-422C-817A-C75BC91779F4Q42277411-05458244-CA19-475D-BA9C-9F0E63C93C57Q43903159-AC8CB816-A637-4E00-BBED-2804DF0F2CC0Q44009612-31652F04-3153-41DA-BD19-4B30F06E46C0Q45944913-B7C64A44-6FCE-4965-9A88-409D90E18948Q46775143-08342851-FD97-459F-9B0D-D7274982E63DQ48152092-7B49E5D8-DB3D-475C-87F1-E2CA06C70293
P2860
Hepatocellular carcinoma in non-alcoholic steatohepatitis: Growing evidence of an epidemic?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Hepatocellular carcinoma in no ...... owing evidence of an epidemic?
@en
Hepatocellular carcinoma in no ...... owing evidence of an epidemic?
@nl
type
label
Hepatocellular carcinoma in no ...... owing evidence of an epidemic?
@en
Hepatocellular carcinoma in no ...... owing evidence of an epidemic?
@nl
prefLabel
Hepatocellular carcinoma in no ...... owing evidence of an epidemic?
@en
Hepatocellular carcinoma in no ...... owing evidence of an epidemic?
@nl
P2860
P1433
P1476
Hepatocellular carcinoma in no ...... owing evidence of an epidemic?
@en
P2093
Etsuko Hashimoto
Katsutoshi Tokushige
P2860
P356
10.1111/J.1872-034X.2011.00872.X
P577
2011-09-15T00:00:00Z